SIRT3 and colorectal cancer: Another study on colorectal cancer cells demonstrated that suppressing SIRT3 re‐sensitized malignant cells to anticancer drugs by inhibiting SOD2, increasing ROS levels, and down‐regulating mitochondria activity.